Buradasınız

FAMİLYAL POLİSİTEMİ TANISI İLE TAKİP EDİLEN İKİ KARDEŞ

FAMILIAL POLYCYTHEMIA IN TWO BROTHERS

Journal Name:

Publication Year:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Familial polycythemia (FP), namely primary familial congenital polycythemia is a rare automosal dominant disorder. FP is characterized by isolated erythrocytosis without evolution into leukemia or other myeloproliferative disorders, absence of splenomegaly, normal white blood cell and platelet counts, low plasma erythropoietin levels and hypersensitivity of erythroid progenitors to exogenous erythropoietin in vitro. We report here two brothers referred to our Hematology Department one of them was 22 years old the and other was 17. They had erytrocytosis and no other pathological findings. After excluding other diseases presenting with polycythemia we diagnosed familial polycythemia. We continue to treat with flebotomy when they are symptomatic.
Abstract (Original Language): 
Familyal polisitemi (FP), tam ismiyle primer familyal konjenital polisitemi nadir görülen otozomal dominant bir hastalıktır. Ġzole eritrositoz ile seyreden bu hastalık; lösemi ile diğer myoleproliferatif hastalıklara dönüĢümün ve splenomegalinin olmaması, normal lökosit ve trombosit sayısı, düĢük eritropoetin düzeyi, in vitro koĢullarda eksojen eritropoetine eritroid progenitörlerin hipersensitivitesi ile karakterizedir. Bu yazıda Hematoloji Polikliniğimize yönlendirilen, izole eritrositoz dıĢında klinik ya da laboratuar bulgusu olmayan, biri 22 diğeri 17 yaĢında iki kardeĢ sunulmuĢtur. Polisitemiye neden olan diğer hastalıklar dıĢlandıktan sonra familyal polisitemi tanısı koyulmuĢtur. Hastalar semptomatik olduklarında flebotomi tedavisi yapılmaktadır.
31-32

REFERENCES

References: 

1. Gordeuk VR, Sergueeva AI, Miasnikova GY, Okhotin D, Voloshin Y, Choyke PL, Butman JA, Jedlickova K, Prchal JT, Polyakova LA. Congenital disorder of oxygen-sensing: Association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood 2004; 103:3924-3932.
2. Gordeuk VR, Stockton DW, Prchal JT. Congenital polycythemias/erythrocytoses. Hematologica, 2005; 90:109-116
3. Juvonen E, Ikkala E, Fyhrquist F, Ruutu T. Autosomal dominant erythrocytosis causes by increased sensitivity to erythropoietin. Blood 1991;78:3066-3069.
4. Kralovics R, Indrak K, Stopka T, Berman BW, Prchal JF, Prchal JT. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias. Blood 1997; 90:2057-2061.
5. Kralovics R, Prchal JT. Genetic heterogeneity of primary familial and congenital polycythemia. Am J Hematol 2001; 68:115-121.
6. Percy MJ, Jones FG, Green AR, Reilly JT, McMullin MF. The incidence of the JAK2 V617F mutation in patients with idiopathic erythrocytosis. Haematologica 2006; 91:413-414.
7. Polyakova LA. Familial erythrocytosis among inhabitants of the Chuvash ASSR. Probl Hematol 1974; 10:30-36.
8. Prchal JT, Crist WM, Goldwasser E, Perrine G, Prchal JF. Autosomal dominant polycythemia. Blood 1985; 66: 1208-1214.
9. Prchal JT, Prchal JF, Semenza GL, Sokol L. Familial polycythemia. Science 1995; 268:1831-1832.
10. Sergeyeva A, Gordeuk VR, Tokarev YN, Sokol L, Prchal JF, Prchal JT. Congenital polycythemia in Chuvashia. Blood 1997; 89:2148-2154.

Thank you for copying data from http://www.arastirmax.com